EDGAR Filing Documents for 0001104659-23-107256

Form 8-K - Current report:

SEC Accession No. 0001104659-23-107256

Filing Date

2023-10-05

Accepted

2023-10-05 17:12:31

Documents

Period of Report

2023-09-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2327139d1_8k.htm iXBRL	8-K	318996
2	EXHIBIT 3.1	tm2327139d1_ex3-1.htm	EX-3.1	37617
3	EXHIBIT 3.2	tm2327139d1_ex3-2.htm	EX-3.2	135439
4	EXHIBIT 4.1	tm2327139d1_ex4-1.htm	EX-4.1	11352
5	EXHIBIT 4.2	tm2327139d1_ex4-2.htm	EX-4.2	27848
6	EXHIBIT 10.1.3	tm2327139d1_ex10d1-3.htm	EX-10.1(3)	28846
7	EXHIBIT 10.6	tm2327139d1_ex10-6.htm	EX-10.6	164743
8	EXHIBIT 10.7.3	tm2327139d1_ex10d7-3.htm	EX-10.7(3)	108231
9	EXHIBIT 10.7.4	tm2327139d1_ex10d7-4.htm	EX-10.7(4)	109583
10	EXHIBIT 10.10	tm2327139d1_ex10-10.htm	EX-10.10	13160
11	EXHIBIT 10.13.2	tm2327139d1_ex10d13-2.htm	EX-10.13(2)	6345
12	EXHIBIT 10.23	tm2327139d1_ex10-23.htm	EX-10.23	25678
13	EXHIBIT 10.24.1	tm2327139d1_ex10d24-1.htm	EX-10.24(1)	191648
14	EXHIBIT 10.24.2	tm2327139d1_ex10d24-2.htm	EX-10.24(2)	54584
15	EXHIBIT 10.24.3	tm2327139d1_ex10d24-3.htm	EX-10.24(3)	34763
16	EXHIBIT 10.25	tm2327139d1_ex10-25.htm	EX-10.25	94947
17	EXHIBIT 10.26	tm2327139d1_ex10-26.htm	EX-10.26	89945
18	EXHIBIT 16.1	tm2327139d1_ex16-1.htm	EX-16.1	2727
19	EXHIBIT 21.1	tm2327139d1_ex21-1.htm	EX-21.1	1447
20	EXHIBIT 99.1	tm2327139d1_ex99-1.htm	EX-99.1	308268
21	EXHIBIT 99.2	tm2327139d1_ex99-2.htm	EX-99.2	179941
22	EXHIBIT 99.3	tm2327139d1_ex99-3.htm	EX-99.3	379675
23	EXHIBIT 99.4	tm2327139d1_ex99-4.htm	EX-99.4	12114
28	GRAPHIC	tm2327139d1_ex10-23img001.jpg	GRAPHIC	33711
29	GRAPHIC	tm2327139d1_ex10-23img002.jpg	GRAPHIC	2850
	Complete submission text file	0001104659-23-107256.txt		3053967

Data Files

Seq	Description	Document	Type	Size
24	XBRL TAXONOMY EXTENSION SCHEMA	gfor-20230929.xsd	EX-101.SCH	3272
25	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	gfor-20230929_def.xml	EX-101.DEF	26915
26	XBRL TAXONOMY EXTENSION LABEL LINKBASE	gfor-20230929_lab.xml	EX-101.LAB	36508
27	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	gfor-20230929_pre.xml	EX-101.PRE	25539
31	EXTRACTED XBRL INSTANCE DOCUMENT	tm2327139d1_8k_htm.xml	XML	5060

Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705

Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830

NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)